1. A Nomogram Based on Molecular Biomarkers and Radiomics to Predict Lymph Node Metastasis in Breast Cancer
   Xiaoming Qiu et al, 2022, Frontiers in Oncology CrossRef
2. Cinobufacini Injection Inhibits the Proliferation of Triple-Negative Breast Cancer Through the Pin1–TAZ Signaling Pathway
   Lu Kong et al, 2022, Frontiers in Pharmacology CrossRef
3. Stem Cell Models for Cancer Therapy
   Nitin Telang, 2022, International Journal of Molecular Sciences CrossRef
4. Network Pharmacology-based Prediction and Verification of Shikonin for Treating Colorectal Cancer
   Peng Song et al, 2022, Recent Patents on Anti-Cancer Drug Discovery CrossRef
5. Gedunin modulates cellular growth and apoptosis in glioblastoma cell lines
   Michael Stouffer et al, 2024, Cancer Reports CrossRef
6. Inositol monophosphatase 1 (IMPA1) promotes triple‐negative breast cancer progression through regulating mTOR pathway and EMT process
   Shao‐Ying Yang et al, 2023, Cancer Medicine CrossRef
7. Phytotherapeutic applications of alkaloids in treating breast cancer
   Shailima Rampogu et al, 2022, Biomedicine & Pharmacotherapy CrossRef
8. The Dibenzyl Isoquinoline Alkaloid Berbamine Ameliorates Osteoporosis by Inhibiting Bone Resorption
   Chongjing Zhang et al, 2022, Frontiers in Endocrinology CrossRef
9. Growth Inhibitory Efficacy of Chinese Herbs in a Cellular Model for Triple-Negative Breast Cancer
   Nitin T. Telang et al, 2021, Pharmaceuticals CrossRef
10. Berbamine, a bioactive alkaloid, suppresses equine herpesvirus type 1 in vitro and in vivo
    Zeyu Li et al, 2023, Frontiers in Veterinary Science CrossRef
11. c-Kit Induces Migration of Triple-Negative Breast Cancer Cells and Is a Promising Target for Tyrosine Kinase Inhibitor Treatment
    José A. López-Mejía et al, 2022, International Journal of Molecular Sciences CrossRef
12. Chromatin Accessibility Landscape of Human Triple-negative Breast Cancer Cell Lines Reveals Variation by Patient Donor Ancestry
    Alexandra R. Harris et al, 2023, Cancer Research Communications CrossRef
13. Regulation of Cell-Signaling Pathways by Berbamine in Different Cancers
    Ammad Ahmad Farooqi et al, 2022, International Journal of Molecular Sciences CrossRef
14. Promises of phytochemical based nano drug delivery systems in the management of cancer
    Parveen Kumar et al, 2022, Chemico-Biological Interactions CrossRef
15. Anti-Tumor and Anti-Metastasis Effects of Berbamine-Loaded Lipid Nanoparticles on Pancreatic Cancer
    Zhiyi Tang et al, 2022, Anti-Cancer Agents in Medicinal Chemistry CrossRef
16. RPN1 promotes the proliferation and invasion of breast cancer cells by activating the PI3K/AKT/mTOR signaling pathway
    Wei-juan Shen et al, 2024, Discover Oncology CrossRef
17. Natural Products/Bioactive Compounds as a Source of Anticancer Drugs
    Syeda Tasmia Asma et al, 2022, Cancers CrossRef
18. Novel Insights into miR-944 in Cancer
    Jinze Shen et al, 2022, Cancers CrossRef
19. MDM2: current research status and prospects of tumor treatment
    Yumei Yao et al, 2024, Cancer Cell International CrossRef
20. Breast cancer drug resistance: Decoding the roles of Hippo pathway crosstalk
    Fariba Dehghanian et al, 2024, Gene CrossRef